Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohit Pratap Singh"'
Autor:
Mohit Pratap Singh, Sri Nandhini Sethuraman, Jerry Ritchey, Steven Fiering, Chandan Guha, Jerry Malayer, Ashish Ranjan
Publikováno v:
International Journal of Hyperthermia, Vol 36, Iss 0, Pp 64-73 (2019)
The success of melanoma immunotherapy is dependent on the presence of activated and functional T-cells in tumors. The objective of this study was to investigate the impact of local-focused ultrasound (FUS) heating (∼42–45 °C) and in-situ anti-CD
Externí odkaz:
https://doaj.org/article/909d1f37a8124fa8979f2ad773e604eb
Autor:
Sri Nandhini Sethuraman, Nicholas Flynn, Carey Pope, Ashish Ranjan, Mohit Pratap Singh, Joshua D. Ramsey, Jerry W. Ritchey, Jing Liu, Saeed Manouchehri
Publikováno v:
Journal of Controlled Release. 329:148-161
Rapid clearance of thrombolytics from blood following intravenous injection is a major clinical challenge in cardiovascular medicine. To overcome this barrier, nanoparticle (NP) based drug delivery systems have been reported. Although superior than c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db1d83217c85f9a8f307838ffbd75e1d
https://doi.org/10.1016/j.jconrel.2020.11.034
https://doi.org/10.1016/j.jconrel.2020.11.034
Autor:
Mohit Pratap Singh, P. Jack Hoopes, Jerry R. Malayer, Shitao Li, Sri Nandhini Sethuraman, Steven Fiering, Ashish Ranjan, Girish Patil, Chandan Guha
Publikováno v:
Theranostics
Rationale: Some studies have shown that the local activation of immunogenic cell death (ICD) by upregulating calreticulin (CRT) expression in solid tumors can improve antitumor effects. Although a promising approach, a key current challenge in ICD tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93909bf5c890a3b82bc4fbcf0cc206de
https://doi.org/10.7150/thno.42243
https://doi.org/10.7150/thno.42243
Autor:
Maria Cristina Munteanu, Ashish Ranjan, Sri Nandhini Sethuraman, Mohit Pratap Singh, Jerry R. Malayer
Publikováno v:
Genes, Vol 12, Iss 897, p 897 (2021)
Genes
Genes
FENDRR (Fetal-lethal non-coding developmental regulatory RNA, LncRNA FOXF1-AS1) is a recently identified tumor suppressor long non-coding (LncRNA) RNA, and its expression has been linked with epigenetic modulation of the target genes involved in tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd45570eb3fb911ee5e6d9e761dfa885
https://www.mdpi.com/2073-4425/12/6/897
https://www.mdpi.com/2073-4425/12/6/897
Autor:
Sri Nandhini Sethuraman, Ashish Ranjan, Mohit Pratap Singh, Craig A. Miller, Jerry R. Malayer
Publikováno v:
Theranostics
Background: Advanced stage cancers with a suppressive tumor microenvironment (TME) are often refractory to immune checkpoint inhibitor (ICI) therapy. Recent studies have shown that focused ultrasound (FUS) TME-modulation can synergize ICI therapy, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a706dfb4fb2f2d4df209a7a97439959
https://pubmed.ncbi.nlm.nih.gov/33391491
https://pubmed.ncbi.nlm.nih.gov/33391491